Sangamo Therapeutics
SGMO
#8836
Rank
A$0.22 B
Marketcap
A$0.66
Share price
3.49%
Change (1 day)
-83.42%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: A$0.22 Billion

As of December 2025 Sangamo Therapeutics has a market cap of A$0.22 Billion. This makes Sangamo Therapeutics the world's 8836th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.22 B-73.99%
2024A$0.85 B507.21%
2023A$0.14 B-81.3%
2022A$0.75 B-49.82%
2021A$1.50 B-47.5%
2020A$2.87 B107.04%
2019A$1.38 B-16.74%
2018A$1.66 B-6.21%
2017A$1.77 B494.16%
2016A$0.29 B-66.11%
2015A$0.88 B-31.3%
2014A$1.28 B32.42%
2013A$0.96 B215.87%
2012A$0.30 B111.13%
2011A$0.14 B-51%
2010A$0.29 B0.04%
2009A$0.29 B46.7%
2008A$0.20 B-66.34%
2007A$0.60 B104.64%
2006A$0.29 B74.26%
2005A$0.16 B-14.07%
2004A$0.19 B6.7%
2003A$0.18 B38.93%
2002A$0.13 B-70.5%
2001A$0.44 B-41.99%
2000A$0.77 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of Sangamo Therapeutics was reported to be:

A$0.21 Billion
by Nasdaq info icon info icon
A$0.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
A$232.63 B 104,035.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$78.97 B 35,252.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$268.28 B 119,995.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$38.59 B 17,175.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$24.45 B 10,845.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$746.85 B 334,214.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$17.24 B 7,618.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$396.67 B 177,467.07%๐Ÿ‡บ๐Ÿ‡ธ USA